Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Dexamethasone in Prevention of the Second Phase or a Biphasic Reaction of Anaphylaxis

NCT03523221 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT03523221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03523221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Dexamethasone in Prevention of the Second Phase or a Biphasic Reaction of Anaphylaxis
Lead sponsor
Hamad Medical Corporation
Phase
Phase 1
Overall status
Recruiting
Start date
April 15, 2018
Completion date
December 31, 2024
Enrollment
210 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaphylaxis